Puerto Rico Bolsters Its Biopharma Hub With R&D, Start-Up Initiatives
Executive Summary
In the past year, Puerto Rico formed a consortium of clinical trial sites, launched a funding program for entrepreneurs and created a technology transfer office – all achievements touted at the Biolatam biotech conference in San Juan.
You may also be interested in...
Gottlieb: Why FDA Must Help Restore Puerto Rico's Pharma Sector
FDA commissioner underscores importance of restoring full production in Puerto Rico, where nearly 10% of all pharmaceuticals consumed in the US are made. Some plants have partially resumed operations under generator power, he notes, but the full recovery that at some point will be needed to prevent shortages will require restoring the island's power grid.
Puerto Rican Pharma Plants Prepare For Hurricane Maria
Pharmaceutical companies race to prepare manufacturing facilities in Puerto Rico, many of which date back to the 1980s and 1990s, for the arrival of Hurricane Maria.
Puerto Rico’s Molecular Sciences Research Center Signals Resurgent Industry
The five-year old center is to include the island’s first preclinical facility. Researchers there are working on an HIV vaccine with support from Amgen, Lilly and the US National Institutes of Health.